Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 61% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $56,687 and 11, calls, for a total amount of $1,877,953.
Projected Price Targets
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $900.0 for Eli Lilly, spanning the last three months.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Eli Lilly's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Eli Lilly's substantial trades, within a strike price spectrum from $300.0 to $900.0 over the preceding 30 days.
Eli Lilly Call and Put Volume: 30-Day Overview
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BEARISH | 01/17/25 | $300.00 | $1.5M | 246 | 0 |
| LLY | CALL | SWEEP | BULLISH | 01/19/24 | $580.00 | $62.3K | 1.1K | 75 |
| LLY | CALL | SWEEP | NEUTRAL | 06/21/24 | $470.00 | $54.3K | 87 | 4 |
| LLY | CALL | SWEEP | BEARISH | 01/26/24 | $585.00 | $42.0K | 74 | 12 |
| LLY | CALL | TRADE | NEUTRAL | 01/19/24 | $585.00 | $37.0K | 50 | 30 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
After a thorough review of the options trading surrounding Eli Lilly, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Eli Lilly's Current Market Status
- With a trading volume of 565,091, the price of LLY is up by 0.49%, reaching $582.61.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 44 days from now.
Expert Opinions on Eli Lilly
2 market experts have recently issued ratings for this stock, with a consensus target price of $640.0.
- Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $630.
- Reflecting concerns, an analyst from Truist Securities lowers its rating to Buy with a new price target of $650.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
